Taku Kouro, Hidetomo Himuro, Tetsuro Sasada. J Transl Med 2022
Times Cited: 3
Times Cited: 3
Times Cited
Times Co-cited
Similarity
Glypican-3-Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular Carcinoma.
Sai Arun Batra, Purva Rathi, Linjie Guo, Amy N Courtney, Julien Fleurence, Julien Balzeau, Rahamthulla S Shaik, Thao P Nguyen, Meng-Fen Wu, Shaun Bulsara,[...]. Cancer Immunol Res 2020
Sai Arun Batra, Purva Rathi, Linjie Guo, Amy N Courtney, Julien Fleurence, Julien Balzeau, Rahamthulla S Shaik, Thao P Nguyen, Meng-Fen Wu, Shaun Bulsara,[...]. Cancer Immunol Res 2020
66
The structural basis of T-cell receptor (TCR) activation: An enduring enigma.
Roy A Mariuzza, Pragati Agnihotri, John Orban. J Biol Chem 2020
Roy A Mariuzza, Pragati Agnihotri, John Orban. J Biol Chem 2020
66
Armored CAR T-cells: utilizing cytokines and pro-inflammatory ligands to enhance CAR T-cell anti-tumour efficacy.
Oladapo O Yeku, Renier J Brentjens. Biochem Soc Trans 2016
Oladapo O Yeku, Renier J Brentjens. Biochem Soc Trans 2016
33
CAR T-cell therapy: is it prime time in myeloma?
Surbhi Sidana, Nina Shah. Hematology Am Soc Hematol Educ Program 2019
Surbhi Sidana, Nina Shah. Hematology Am Soc Hematol Educ Program 2019
33
CD28-ζ CAR T Cells Resist TGF-β Repression through IL-2 Signaling, Which Can Be Mimicked by an Engineered IL-7 Autocrine Loop.
Viktória Golumba-Nagy, Johannes Kuehle, Andreas A Hombach, Hinrich Abken. Mol Ther 2018
Viktória Golumba-Nagy, Johannes Kuehle, Andreas A Hombach, Hinrich Abken. Mol Ther 2018
33
Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies.
Harjeet Singh, Matthew J Figliola, Margaret J Dawson, Helen Huls, Simon Olivares, Kirsten Switzer, Tiejuan Mi, Sourindra Maiti, Partow Kebriaei, Dean A Lee,[...]. Cancer Res 2011
Harjeet Singh, Matthew J Figliola, Margaret J Dawson, Helen Huls, Simon Olivares, Kirsten Switzer, Tiejuan Mi, Sourindra Maiti, Partow Kebriaei, Dean A Lee,[...]. Cancer Res 2011
33
T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia.
Michael Kalos, Bruce L Levine, David L Porter, Sharyn Katz, Stephan A Grupp, Adam Bagg, Carl H June. Sci Transl Med 2011
Michael Kalos, Bruce L Levine, David L Porter, Sharyn Katz, Stephan A Grupp, Adam Bagg, Carl H June. Sci Transl Med 2011
33
Inducible Caspase-9 Selectively Modulates the Toxicities of CD19-Specific Chimeric Antigen Receptor-Modified T Cells.
Iulia Diaconu, Brandon Ballard, Ming Zhang, Yuhui Chen, John West, Gianpietro Dotti, Barbara Savoldo. Mol Ther 2017
Iulia Diaconu, Brandon Ballard, Ming Zhang, Yuhui Chen, John West, Gianpietro Dotti, Barbara Savoldo. Mol Ther 2017
33
Primary human T lymphocytes engineered with a codon-optimized IL-15 gene resist cytokine withdrawal-induced apoptosis and persist long-term in the absence of exogenous cytokine.
Cary Hsu, Marybeth S Hughes, Zhili Zheng, Regina B Bray, Steven A Rosenberg, Richard A Morgan. J Immunol 2005
Cary Hsu, Marybeth S Hughes, Zhili Zheng, Regina B Bray, Steven A Rosenberg, Richard A Morgan. J Immunol 2005
33
Evolving Paradigms of Therapy for Multiple Myeloma: State of the Art and Future Directions.
Scott R Goldsmith, Ravi Vij. JCO Oncol Pract 2021
Scott R Goldsmith, Ravi Vij. JCO Oncol Pract 2021
50
Tumor-targeted T cells modified to secrete IL-12 eradicate systemic tumors without need for prior conditioning.
Hollie J Pegram, James C Lee, Erik G Hayman, Gavin H Imperato, Thomas F Tedder, Michel Sadelain, Renier J Brentjens. Blood 2012
Hollie J Pegram, James C Lee, Erik G Hayman, Gavin H Imperato, Thomas F Tedder, Michel Sadelain, Renier J Brentjens. Blood 2012
33
Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma: A Meta-analysis.
Nikhil C Munshi, Herve Avet-Loiseau, Andy C Rawstron, Roger G Owen, J Anthony Child, Anjan Thakurta, Paul Sherrington, Mehmet Kemal Samur, Anna Georgieva, Kenneth C Anderson,[...]. JAMA Oncol 2017
Nikhil C Munshi, Herve Avet-Loiseau, Andy C Rawstron, Roger G Owen, J Anthony Child, Anjan Thakurta, Paul Sherrington, Mehmet Kemal Samur, Anna Georgieva, Kenneth C Anderson,[...]. JAMA Oncol 2017
33
Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma.
Georgina S F Anderson, Jose Ballester-Beltran, George Giotopoulos, Jose A Guerrero, Sylvanie Surget, James C Williamson, Tsz So, David Bloxham, Anna Aubareda, Ryan Asby,[...]. Blood 2022
Georgina S F Anderson, Jose Ballester-Beltran, George Giotopoulos, Jose A Guerrero, Sylvanie Surget, James C Williamson, Tsz So, David Bloxham, Anna Aubareda, Ryan Asby,[...]. Blood 2022
33
Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen.
Marijke Timmers, Gils Roex, Yuedi Wang, Diana Campillo-Davo, Viggo F I Van Tendeloo, Yiwei Chu, Zwi N Berneman, Feifei Luo, Heleen H Van Acker, Sébastien Anguille. Front Immunol 2019
Marijke Timmers, Gils Roex, Yuedi Wang, Diana Campillo-Davo, Viggo F I Van Tendeloo, Yiwei Chu, Zwi N Berneman, Feifei Luo, Heleen H Van Acker, Sébastien Anguille. Front Immunol 2019
33
Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors.
Z Eshhar, T Waks, G Gross, D G Schindler. Proc Natl Acad Sci U S A 1993
Z Eshhar, T Waks, G Gross, D G Schindler. Proc Natl Acad Sci U S A 1993
33
Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma.
Gils Roex, Marijke Timmers, Kristien Wouters, Diana Campillo-Davo, Donovan Flumens, Wilfried Schroyens, Yiwei Chu, Zwi N Berneman, Eva Lion, Feifei Luo,[...]. J Hematol Oncol 2020
Gils Roex, Marijke Timmers, Kristien Wouters, Diana Campillo-Davo, Donovan Flumens, Wilfried Schroyens, Yiwei Chu, Zwi N Berneman, Eva Lion, Feifei Luo,[...]. J Hematol Oncol 2020
33
CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma.
Sabrina Prommersberger, Michael Reiser, Julia Beckmann, Sophia Danhof, Maximilian Amberger, Patricia Quade-Lyssy, Hermann Einsele, Michael Hudecek, Halvard Bonig, Zoltán Ivics. Gene Ther 2021
Sabrina Prommersberger, Michael Reiser, Julia Beckmann, Sophia Danhof, Maximilian Amberger, Patricia Quade-Lyssy, Hermann Einsele, Michael Hudecek, Halvard Bonig, Zoltán Ivics. Gene Ther 2021
33
Chimeric antigen receptor therapy for cancer.
David M Barrett, Nathan Singh, David L Porter, Stephan A Grupp, Carl H June. Annu Rev Med 2014
David M Barrett, Nathan Singh, David L Porter, Stephan A Grupp, Carl H June. Annu Rev Med 2014
33
Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule.
A Hombach, A Wieczarkowiecz, T Marquardt, C Heuser, L Usai, C Pohl, B Seliger, H Abken. J Immunol 2001
A Hombach, A Wieczarkowiecz, T Marquardt, C Heuser, L Usai, C Pohl, B Seliger, H Abken. J Immunol 2001
33
Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma-Challenges and Potential Solutions.
Samer Al Hadidi, Maurizio Zangari, Frits van Rhee. JAMA Oncol 2022
Samer Al Hadidi, Maurizio Zangari, Frits van Rhee. JAMA Oncol 2022
33
CD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial Diagnosis.
Jeannette Fischer, Claudia Paret, Khalifa El Malki, Francesca Alt, Arthur Wingerter, Marie A Neu, Bettina Kron, Alexandra Russo, Nadine Lehmann, Lea Roth,[...]. J Immunother 2017
Jeannette Fischer, Claudia Paret, Khalifa El Malki, Francesca Alt, Arthur Wingerter, Marie A Neu, Bettina Kron, Alexandra Russo, Nadine Lehmann, Lea Roth,[...]. J Immunother 2017
33
Multiple myeloma: 2020 update on diagnosis, risk-stratification and management.
S Vincent Rajkumar. Am J Hematol 2020
S Vincent Rajkumar. Am J Hematol 2020
33
Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma.
Matteo C Da Vià, Oliver Dietrich, Marietta Truger, Panagiota Arampatzi, Johannes Duell, Anke Heidemeier, Xiang Zhou, Sophia Danhof, Sabrina Kraus, Manik Chatterjee,[...]. Nat Med 2021
Matteo C Da Vià, Oliver Dietrich, Marietta Truger, Panagiota Arampatzi, Johannes Duell, Anke Heidemeier, Xiang Zhou, Sophia Danhof, Sabrina Kraus, Manik Chatterjee,[...]. Nat Med 2021
33
CAR T Cells and Other Cellular Therapies for Multiple Myeloma: 2018 Update.
Adam D Cohen. Am Soc Clin Oncol Educ Book 2018
Adam D Cohen. Am Soc Clin Oncol Educ Book 2018
33
An early history of T cell-mediated cytotoxicity.
Pierre Golstein, Gillian M Griffiths. Nat Rev Immunol 2018
Pierre Golstein, Gillian M Griffiths. Nat Rev Immunol 2018
33
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study.
Jesus G Berdeja, Deepu Madduri, Saad Z Usmani, Andrzej Jakubowiak, Mounzer Agha, Adam D Cohen, A Keith Stewart, Parameswaran Hari, Myo Htut, Alexander Lesokhin,[...]. Lancet 2021
Jesus G Berdeja, Deepu Madduri, Saad Z Usmani, Andrzej Jakubowiak, Mounzer Agha, Adam D Cohen, A Keith Stewart, Parameswaran Hari, Myo Htut, Alexander Lesokhin,[...]. Lancet 2021
33
Intravenous safety and pharmacokinetics of a novel dimerizer drug, AP1903, in healthy volunteers.
J D Iuliucci, S D Oliver, S Morley, C Ward, J Ward, D Dalgarno, T Clackson, H J Berger. J Clin Pharmacol 2001
J D Iuliucci, S D Oliver, S Morley, C Ward, J Ward, D Dalgarno, T Clackson, H J Berger. J Clin Pharmacol 2001
33
Antibody-dependent cellular cytotoxicity (ADCC) is mediated by genetically modified antigen-specific human T lymphocytes.
Béatrice Clémenceau, Nicolas Congy-Jolivet, Géraldine Gallot, Régine Vivien, Joëlle Gaschet, Gilles Thibault, Henri Vié. Blood 2006
Béatrice Clémenceau, Nicolas Congy-Jolivet, Géraldine Gallot, Régine Vivien, Joëlle Gaschet, Gilles Thibault, Henri Vié. Blood 2006
33
Development of CAR T Cells Expressing a Suicide Gene Plus a Chimeric Antigen Receptor Targeting Signaling Lymphocytic-Activation Molecule F7.
Christina Amatya, Melissa A Pegues, Norris Lam, Danielle Vanasse, Claudia Geldres, Stephanie Choi, Stephen M Hewitt, Steven A Feldman, James N Kochenderfer. Mol Ther 2021
Christina Amatya, Melissa A Pegues, Norris Lam, Danielle Vanasse, Claudia Geldres, Stephanie Choi, Stephen M Hewitt, Steven A Feldman, James N Kochenderfer. Mol Ther 2021
33
Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy.
Shih-Feng Cho, Kenneth C Anderson, Yu-Tzu Tai. Front Immunol 2018
Shih-Feng Cho, Kenneth C Anderson, Yu-Tzu Tai. Front Immunol 2018
33
Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety.
V Hoyos, B Savoldo, C Quintarelli, A Mahendravada, M Zhang, J Vera, H E Heslop, C M Rooney, M K Brenner, G Dotti. Leukemia 2010
V Hoyos, B Savoldo, C Quintarelli, A Mahendravada, M Zhang, J Vera, H E Heslop, C M Rooney, M K Brenner, G Dotti. Leukemia 2010
33
The generation of antibody-secreting plasma cells.
Stephen L Nutt, Philip D Hodgkin, David M Tarlinton, Lynn M Corcoran. Nat Rev Immunol 2015
Stephen L Nutt, Philip D Hodgkin, David M Tarlinton, Lynn M Corcoran. Nat Rev Immunol 2015
33
Parallel detection of transduced T lymphocytes after immunogene therapy of renal cell cancer by flow cytometry and real-time polymerase chain reaction: implications for loss of transgene expression.
C H J Lamers, J W Gratama, N M C Pouw, S C L Langeveld, B A Van Krimpen, J Kraan, G Stoter, R Debets. Hum Gene Ther 2005
C H J Lamers, J W Gratama, N M C Pouw, S C L Langeveld, B A Van Krimpen, J Kraan, G Stoter, R Debets. Hum Gene Ther 2005
33
Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma.
Meenakshi Hegde, Amanda Corder, Kevin K H Chow, Malini Mukherjee, Aidin Ashoori, Yvonne Kew, Yi Jonathan Zhang, David S Baskin, Fatima A Merchant, Vita S Brawley,[...]. Mol Ther 2013
Meenakshi Hegde, Amanda Corder, Kevin K H Chow, Malini Mukherjee, Aidin Ashoori, Yvonne Kew, Yi Jonathan Zhang, David S Baskin, Fatima A Merchant, Vita S Brawley,[...]. Mol Ther 2013
33
HOMOGRAFT TARGET CELLS: SPECIFIC DESTRUCTION IN VITRO BY CONTACT INTERACTION WITH IMMUNE MACROPHAGES.
G A GRANGER, R S WEISER. Science 1964
G A GRANGER, R S WEISER. Science 1964
33
Risk Factors Associated with Durable Progression-Free Survival in Patients with Relapsed or Refractory Multiple Myeloma Treated with Anti-BCMA CAR T-cell Therapy.
Mingming Zhang, Linghui Zhou, Houli Zhao, Yanlei Zhang, Guoqing Wei, Ruimin Hong, Wenjun Wu, Huijun Xu, Linqin Wang, Fang Ni,[...]. Clin Cancer Res 2021
Mingming Zhang, Linghui Zhou, Houli Zhao, Yanlei Zhang, Guoqing Wei, Ruimin Hong, Wenjun Wu, Huijun Xu, Linqin Wang, Fang Ni,[...]. Clin Cancer Res 2021
33
B cell maturation antigen-specific chimeric antigen receptor T cells for relapsed or refractory multiple myeloma: A meta-analysis.
Nico Gagelmann, Francis Ayuk, Djordje Atanackovic, Nicolaus Kröger. Eur J Haematol 2020
Nico Gagelmann, Francis Ayuk, Djordje Atanackovic, Nicolaus Kröger. Eur J Haematol 2020
33
Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.
Stephan A Grupp, Michael Kalos, David Barrett, Richard Aplenc, David L Porter, Susan R Rheingold, David T Teachey, Anne Chew, Bernd Hauck, J Fraser Wright,[...]. N Engl J Med 2013
Stephan A Grupp, Michael Kalos, David Barrett, Richard Aplenc, David L Porter, Susan R Rheingold, David T Teachey, Anne Chew, Bernd Hauck, J Fraser Wright,[...]. N Engl J Med 2013
33
CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity.
Elad Jacoby, Sang M Nguyen, Thomas J Fountaine, Kathryn Welp, Berkley Gryder, Haiying Qin, Yinmeng Yang, Christopher D Chien, Alix E Seif, Haiyan Lei,[...]. Nat Commun 2016
Elad Jacoby, Sang M Nguyen, Thomas J Fountaine, Kathryn Welp, Berkley Gryder, Haiying Qin, Yinmeng Yang, Christopher D Chien, Alix E Seif, Haiyan Lei,[...]. Nat Commun 2016
33
INHIBITION OF ANTIBODY PLAQUE FORMATION BY SENSITIZED LYMPHOID CELLS: RAPID INDICATOR OF TRANSPLANTATION IMMUNITY.
H FRIEDMAN. Science 1964
H FRIEDMAN. Science 1964
33
CD19-CAR-T Cells Bearing a KIR/PD-1-Based Inhibitory CAR Eradicate CD19+HLA-C1- Malignant B Cells While Sparing CD19+HLA-C1+ Healthy B Cells.
Lei Tao, Muhammad Asad Farooq, Yaoxin Gao, Li Zhang, Congyi Niu, Iqra Ajmal, Ying Zhou, Cong He, Guixia Zhao, Jie Yao,[...]. Cancers (Basel) 2020
Lei Tao, Muhammad Asad Farooq, Yaoxin Gao, Li Zhang, Congyi Niu, Iqra Ajmal, Ying Zhou, Cong He, Guixia Zhao, Jie Yao,[...]. Cancers (Basel) 2020
33
Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma.
Markus Chmielewski, Andreas A Hombach, Hinrich Abken. Immunol Rev 2014
Markus Chmielewski, Andreas A Hombach, Hinrich Abken. Immunol Rev 2014
33
A Rapamycin-Activated Caspase 9-Based Suicide Gene.
Maria Stavrou, Brian Philip, Charlotte Traynor-White, Christopher G Davis, Shimobi Onuoha, Shaun Cordoba, Simon Thomas, Martin Pule. Mol Ther 2018
Maria Stavrou, Brian Philip, Charlotte Traynor-White, Christopher G Davis, Shimobi Onuoha, Shaun Cordoba, Simon Thomas, Martin Pule. Mol Ther 2018
33
Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma.
Muthulekha Swamydas, Elena V Murphy, James J Ignatz-Hoover, Ehsan Malek, James J Driscoll. J Hematol Oncol 2022
Muthulekha Swamydas, Elena V Murphy, James J Ignatz-Hoover, Ehsan Malek, James J Driscoll. J Hematol Oncol 2022
33
Targeting Proteasomes in Cancer and Infectious Disease: A Parallel Strategy to Treat Malignancies and Microbes.
James J Ignatz-Hoover, Elena V Murphy, James J Driscoll. Front Cell Infect Microbiol 2022
James J Ignatz-Hoover, Elena V Murphy, James J Driscoll. Front Cell Infect Microbiol 2022
50
Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities.
Bénedith Oben, Guy Froyen, Kylee H Maclachlan, Daniel Leongamornlert, Federico Abascal, Binbin Zheng-Lin, Venkata Yellapantula, Andriy Derkach, Ellen Geerdens, Benjamin T Diamond,[...]. Nat Commun 2021
Bénedith Oben, Guy Froyen, Kylee H Maclachlan, Daniel Leongamornlert, Federico Abascal, Binbin Zheng-Lin, Venkata Yellapantula, Andriy Derkach, Ellen Geerdens, Benjamin T Diamond,[...]. Nat Commun 2021
33
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.